Image of the Day: Meiosis Researcher, Olympic Hopeful

Olivia Ballew, a graduate student at Indiana University, is currently writing her dissertation while preparing to compete in the upcoming Olympic marathon trials.

Written byAmy Schleunes
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Olivia Ballew knows the difficulties of both science and running, but “if I had to pick,” she tells The Scientist, “I would say that getting a PhD is much harder than qualifying for the Olympic Trials.”

It was Ballew’s time in the Indianapolis Monumental Marathon in November 2018—2:43:15—that qualified her to compete in the Olympic trials to be held later this week in Atlanta. The top runners will advance to the summer Olympics in Tokyo this July. Ballew has been training for the run as she simultaneously writes her dissertation on meiotic commitment in yeast cells.

Her research in Soni Lacefield’s lab at Indiana University investigates what keeps a cell in meiosis once it decides to undergo the process, and she has found that knocking out two meiotic checkpoints—one in yeast cells and another in mammalian cells—results in a loss of meiotic commitment.

As the trials approach, she has been ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A former intern at The Scientist, Amy studied neurobiology at Cornell University and later earned her MFA in creative writing from the University of Iowa. She is a Los Angeles–based writer, editor, and communications strategist who collaborates on nonfiction books for Harper Collins and Houghton Mifflin Harcourt, and also teaches writing at Johns Hopkins University CTY. Her favorite projects involve sharing the insights of science and medicine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies